Comparison of renal function of the patients receiving linagliptin or vildagliptin in uncontrolled type 2 diabetes mellitus: An observational study in the backdrop of the COVID-19 pandemic.

Indian J Pharmacol · 2025 · PMC12370227 · PMID 40686358

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

reported a decreasing trend in LDL, total cholesterol, and triglyceride, in patients with 12-week administration of vildagliptin or linagliptin.[ 25 ] Furthermore, a decrease in the SGPT level was observed in both the groups, and it was more in the linagliptin group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.